Q3 2020 Holdings
Filed 2020-11-12 | 9 holdings | $60.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Fate Therapeutics, Inc.(FATE) | Common Stock | 31189P102 | $34.2K | 854,836 | 56.3% |
| Lyra Therapeutics, Inc.(LYRA) | Common Stock | 55234L105 | $12.3K | 1,100,852 | 20.3% |
| Selecta Biosciences, Inc.(SELBUSD) | Common Stock | 816212104 | $6.9K | 2,773,479 | 11.3% |
| Neuronetics, Inc.(STIM) | Common Stock | 64131A105 | $3.6K | 732,583 | 5.9% |
| x4 Pharmaceuticals Inc.(ASNSUSD) | Common Stock | 98420X103 | $2.1K | 311,492 | 3.5% |
| Genocea Biosciences, Inc.(GNCAQ) | Common Stock | 372427401 | $452 | 197,345 | 0.7% |
| Pulmatrix, Inc. | Common Stock | 74584P202 | $428 | 359,441 | 0.7% |
| Atyr Pharma Inc.(LIFEUSD) | Common Stock | 002120103 | $422 | 130,572 | 0.7% |
| Dare Bioscience, Inc.(CERUEUR) | Common Stock | 23666P101 | $326 | 326,240 | 0.5% |